Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. 1988

F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
Department of Virology, Karolinska Institute, Stockholm, Sweden.

Sera and CSF from 29 patients in early and late stages of HIV infection were analysed for intrathecal antibody production. Elevated CSF-IgG indices indicating intrathecal IgG synthesis were demonstrated in 9 patients while 4 of 18 patients tested had oligoclonal IgG bands in the CSF. Analysis of HIV-specific antibodies by enzyme-linked immunosorbent assay (whole antigen and site-directed ELISA) and calculation of "antibody indices" (CSF/serum antibody quotient divided by CSF/serum albumin quotient) indicated intrathecal HIV antibody synthesis in 19 patients. Analysis of serum and CSF antibodies by an imprint immunofixation (IIF) method showed intrathecal synthesis of predominantly polyclonal HIV-IgG antibodies in 11 of 13 patients examined. IIF analysis of antibodies to six other infectious agents showed no intrathecal antibody production except in one patient who had minor fractions of intrathecally synthesized IgG antibodies to varicella zoster virus. The present results demonstrate that an intrathecal HIV-specific antibody response may be present in both early and late stages of HIV infection, and indicates that HIV may reach the brain at an early stage of infection.

UI MeSH Term Description Entries
D007142 Immunoglobulin gamma-Chains Heavy chains of IMMUNOGLOBULIN G having a molecular weight of approximately 51 kDa. They contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment constant region. The gamma heavy chain subclasses (for example, gamma 1, gamma 2a, and gamma 2b) of the IMMUNOGLOBULIN G isotype subclasses (IgG1, IgG2A, and IgG2B) resemble each other more closely than the heavy chains of the other IMMUNOGLOBULIN ISOTYPES. Immunoglobulins, gamma-Chain,Immunoglobulin gamma-Chain,gamma Immunoglobulin Heavy Chain,gamma Immunoglobulin Heavy Chains,gamma-1-Immunoglobulin Heavy Chain,gamma-2a-Immunoglobulin Heavy Chain,gamma-2b-Immunoglobulin Heavy Chain,gamma-Chain Immunoglobulins,Heavy Chain, gamma-1-Immunoglobulin,Heavy Chain, gamma-2a-Immunoglobulin,Heavy Chain, gamma-2b-Immunoglobulin,Immunoglobulin gamma Chain,Immunoglobulin gamma Chains,Immunoglobulins, gamma Chain,gamma 1 Immunoglobulin Heavy Chain,gamma 2a Immunoglobulin Heavy Chain,gamma 2b Immunoglobulin Heavy Chain,gamma Chain Immunoglobulins,gamma-Chain, Immunoglobulin,gamma-Chains, Immunoglobulin
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
September 1987, Journal of clinical microbiology,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
January 1981, American journal of veterinary research,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
November 1992, Journal of clinical microbiology,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
January 1979, Journal of immunological methods,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
April 1988, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
February 1983, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
January 1992, Archives of virology,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
July 2013, Analytical chemistry,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
November 1983, American journal of veterinary research,
F Chiodi, and G Norkrans, and L Hagberg, and A Sönnerborg, and H Gaines, and S Frøland, and E M Fenyö, and E Norrby, and B Vandvik
June 1980, Israel journal of medical sciences,
Copied contents to your clipboard!